Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing

被引:179
作者
Mengstie, Misganaw Asmamaw [1 ]
Wondimu, Belay Zawdie [2 ]
机构
[1] Debre Tabor Univ, Coll Med & Hlth Sci, Dept Biomed Sci, Div Biochem, Debre Tabor, Ethiopia
[2] Jimma Univ, Inst Hlth, Dept Biomed Sci, Div Biochem, Jimma, Ethiopia
关键词
CRISPR; Cas-9; sgRNA; gene-editing; mechanism; applications; CRISPR/CAS9; CRISPR-CAS9; TALEN; GENE; CFTR;
D O I
10.2147/BTT.S326422
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Clustered regularly interspaced short palindromic repeat (CRISPR) and their associated protein (Cas-9) is the most effective, efficient, and accurate method of genome editing tool in all living cells and utilized in many applied disciplines. Guide RNA (gRNA) and CRISPR-associated (Cas-9) proteins are the two essential components in CRISPR/Cas-9 system. The mechanism of CRISPR/Cas-9 genome editing contains three steps, recognition, cleavage, and repair. The designed sgRNA recognizes the target sequence in the gene of interest through a complementary base pair. While the Cas-9 nuclease makes double-stranded breaks at a site 3 base pair upstream to protospacer adjacent motif, then the double-stranded break is repaired by either non-homologous end joining or homology-directed repair cellular mechanisms. The CRISPR/Cas-9 genome-editing tool has a wide number of applications in many areas including medicine, agriculture, and biotechnology. In agriculture, it could help in the design of new grains to improve their nutritional value. In medicine, it is being investigated for cancers, HIV, and gene therapy such as sickle cell disease, cystic fibrosis, and Duchenne muscular dystrophy. The technology is also being utilized in the regulation of specific genes through the advanced modification of Cas-9 protein. However, immunogenicity, effective delivery systems, off-target effect, and ethical issues have been the major barriers to extend the technology in clinical applications. Although CRISPR/Cas-9 becomes a new era in molecular biology and has countless roles ranging from basic molecular researches to clinical applications, there are still challenges to rub in the practical applications and various improvements are needed to overcome obstacles.
引用
收藏
页码:353 / 361
页数:9
相关论文
共 75 条
  • [11] Identification of preexisting adaptive immunity to Cas9 proteins in humans
    Charlesworth, Carsten T.
    Deshpande, Priyanka S.
    Dever, Daniel P.
    Camarena, Joab
    Lemgart, Viktor T.
    Cromer, M. Kyle
    Vakulskas, Christopher A.
    Collingwood, Michael A.
    Zhang, Liyang
    Bode, Nicole M.
    Behlke, Mark A.
    Dejene, Beruh
    Cieniewicz, Brandon
    Romano, Rosa
    Lesch, Benjamin J.
    Gomez-Ospina, Natalia
    Mantri, Sruthi
    Pavel-Dinu, Mara
    Weinberg, Kenneth I.
    Porteus, Matthew H.
    [J]. NATURE MEDICINE, 2019, 25 (02) : 249 - +
  • [12] CRISPR system: Discovery, development and off-target detection
    Chen, Shengmiao
    Yao, Yufeng
    Zhang, Yanchun
    Fan, Gaofeng
    [J]. CELLULAR SIGNALLING, 2020, 70
  • [13] CRISPR technologies and the search for the PAM-free nuclease
    Collias, Daphne
    Beisel, Chase L.
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [14] The long and winding road: stem cells for cystic fibrosis
    Conese, Massimo
    Beccia, Elisa
    Castellani, Stefano
    Di Gioia, Sante
    Colombo, Carla
    Angiolillo, Antonella
    Carbone, Annalucia
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (03) : 281 - 292
  • [15] STRUCTURE, GATING, AND REGULATION OF THE CFTR ANION CHANNEL
    Csanady, Laszlo
    Vergani, Paola
    Gadsby, David C.
    [J]. PHYSIOLOGICAL REVIEWS, 2019, 99 (01) : 707 - 738
  • [16] The switch from fetal to adult erythropoiesis
    Dame, C
    Juul, SE
    [J]. CLINICS IN PERINATOLOGY, 2000, 27 (03) : 507 - +
  • [17] CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges
    Demirci, Selami
    Leonard, Alexis
    Haro-Mora, Juan J.
    Uchida, Naoya
    Tisdale, John F.
    [J]. CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 5, STEM CELLS: TRANSLATIONAL SCIENCE TO THERAPY, 2019, 1144 : 37 - 52
  • [18] Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation
    Dominguez, Antonia A.
    Lim, Wendell A.
    Qi, Lei S.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2016, 17 (01) : 5 - 15
  • [19] Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
    Duan, Li
    Ouyang, Kan
    Xu, Xiao
    Xu, Limei
    Wen, Caining
    Zhou, Xiaoying
    Qin, Zhuan
    Xu, Zhiyi
    Sun, Wei
    Liang, Yujie
    [J]. FRONTIERS IN GENETICS, 2021, 12
  • [20] Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease
    Esrick, Erica B.
    Lehmann, Leslie E.
    Biffi, Alessandra
    Achebe, Maureen
    Brendel, Christian
    Ciuculescu, Marioara F.
    Daley, Heather
    MacKinnon, Brenda
    Morris, Emily
    Federico, Amy
    Abriss, Daniela
    Boardman, Kari
    Khelladi, Radia
    Shaw, Kit
    Negre, Helene
    Negre, Olivier
    Nikiforow, Sarah
    Ritz, Jerome
    Pai, Sung-Yun
    London, Wendy B.
    Dansereau, Colleen
    Heeney, Matthew M.
    Armant, Myriam
    Manis, John P.
    Williams, David A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03) : 205 - 215